The drugmaker gained more than 4% after it said it would integrate OpenAI’s models across its operations to help analyze complex datasets and deliver treatments faster.
The drugmaker gained more than 4% after it said it would integrate OpenAI’s models across its operations to help analyze complex datasets and deliver treatments faster.